Skip to main content

2026 ranking

Best hospitals for Transarterial Chemoembolisation (TACE) in 🇮🇳 India

8 hospitals from the Medcasts database, ordered by centre-of-excellence status, patient rating and review count. Use it as a shortlist, not a verdict.

Methodology: how we rank · pricing

Hospitals ranked
8Hospitals ranked
Average rating
4.5Average rating
  1. Indraprastha Apollo Hospital, Sarita Vihar, New Delhi — main building seen across landscaped gardens 01 Gold
    Center of excellence 🇮🇳 New Delhi, India
    Indraprastha Apollo Hospital

    Why #1: Center of Excellence in transarterial chemoembolisation (tace) · 4.9 rating across 520 reviews

    Indraprastha Apollo is the flagship hospital of the Apollo Group in New Delhi. A 700-bed facility offering a wide range of specialties with JCI accreditation and India's first proton therapy center. Founded in 1996, the …

    ★ 4.9 · 520 reviews 700 beds Est. 1996
    From
    $5,140
    all-in · case-specific
  2. Medanta – The Medicity main building in Sector 38, Gurugram 02 Silver
    Center of excellence 🇮🇳 Gurugram, India
    Medanta - The Medicity

    Why #2: Center of Excellence in transarterial chemoembolisation (tace) · 4.7 rating across 412 reviews

    Medanta is a multi-super specialty hospital founded by Dr. Naresh Trehan. Known for comprehensive care across 20+ specialties with 1600 beds, advanced research facilities, and world-class cardiac care.

    ★ 4.7 · 412 reviews 1,600 beds Est. 2009
    From
    $5,300
    all-in · case-specific
  3. Max Super Speciality Hospital, Saket, New Delhi — entrance block 03 Bronze
    Center of excellence 🇮🇳 New Delhi, India
    Max Super Speciality Hospital, Saket

    Why #3: Designated Center of Excellence with dedicated program volume in transarterial chemoembolisation (tace)

    Max Saket is part of the Max Healthcare network. A leading 500-bed hospital known for cardiac sciences, orthopaedics, and oncology with JCI accreditation. Founded in 2006, the hospital sits in New Delhi, India. Clinical …

    ★ 4.3 · 320 reviews 500 beds Est. 2006
    From
    $4,960
    all-in · case-specific
  4. Sarvodaya Hospital buildings, Faridabad, seen from above 04
    Center of excellence 🇮🇳 Faridabad, India
    Sarvodaya Hospital

    Why #4: Designated Center of Excellence with dedicated program volume in transarterial chemoembolisation (tace)

    Sarvodaya Hospital is a multi-specialty healthcare facility in Faridabad offering comprehensive medical services with modern infrastructure and experienced medical professionals. Founded in 2008, the hospital sits in Far…

    ★ 4.1 · 150 reviews 500 beds Est. 2008
    From
    $6,030
    all-in · case-specific
  5. Artemis Hospital, Sector 51, Gurugram — glass-fronted main building 05
    🇮🇳 Gurugram, India
    Artemis Hospital

    Why #5: Large multi-specialty centre (600+ beds) — broad consultative depth

    Artemis Hospital is a JCI and NABH accredited hospital in Gurgaon, India. The hospital was founded in 2007 by the promoters of the Apollo Group, as a multi specialty hospital providing research and technology oriented …

    ★ 4.5 · 285 reviews 600 beds Est. 2007
    From
    $5,480
    all-in · case-specific
  6. Amrita Hospital campus, Sector 88, Faridabad 06
    🇮🇳 Faridabad, India
    Amrita Hospital Faridabad

    Why #6: Large multi-specialty centre (2,600+ beds) — broad consultative depth

    Amrita Hospital is a private tertiary care hospital in Faridabad, NCR Delhi, India. It is the largest private multi-specialist and superspeciality hospital in Asia, and was inaugurated by Prime Minister Narendra Modi. It…

    ★ 4.4 · 180 reviews 2,600 beds Est. 2022
    From
    $5,110
    all-in · case-specific
  7. National Institute of Mental Health and Neurosciences 07
    🇮🇳 Bengaluru, India
    National Institute of Mental Health and Neurosciences

    Why #7: Established 1974 — long institutional track record

    The National Institute of Mental Health and Neuro-Sciences (NIMHANS) is a medical institution in Bengaluru, India. NIMHANS serves as the apex centre for mental health education and neuroscience research in the country. I…

    Est. 1974
    From
    $5,850
    all-in · case-specific
  8. Aravind Eye Hospital 08
    🇮🇳 Madurai, India
    Aravind Eye Hospital

    Why #8: Established 1976 — long institutional track record

    Aravind Eye Hospitals is a hospital chain in India. It was founded by Dr. Govindappa Venkataswamy at Madurai, Tamil Nadu in 1976. It has grown into a network of eye hospitals and has had a major impact in eradicating cat…

    Est. 1976
    From
    $6,010
    all-in · case-specific

How this list is ordered

What decides the order

Hospitals are sorted by these database fields, in this order. Nothing else is weighted.

We do not score outcomes, surgeon case volume or publications. Ask each hospital for surgeon-level case numbers before you decide.

  1. 1
    Centre-of-excellence flag

    Hospitals marked as a centre of excellence for this specialty come first.

  2. 2
    Patient rating

    A higher average rating ranks higher.

  3. 3
    Number of reviews

    Breaks ties between hospitals with the same rating.

  4. 4
    Lowest listed price

    For a single procedure, a lower listed starting price breaks any remaining tie.

What this list isn't

Rating ≠ outcome

A hospital ranking is a qualifying filter, not a prediction of your outcome. Within any listed hospital, your outcome is shaped by your specific surgeon's volume, the program's protocol for your indication, and your own clinical baseline. Always ask for surgeon-level data — case volume per year, conversion rate, infection rate — before committing.

Next step · Transarterial Chemoembolisation (TACE)

Ready when you are.

Three ways forward. Pick the one that fits where you are right now.

Destination · India

Why patients choose India for transarterial chemoembolisation (tace) (oncology)

India runs one of the world's deepest tertiary-care networks for international patients — over 700 NABH-accredited hospitals and 38+ JCI-accredited facilities, concentrated in Delhi-NCR, Chennai, Mumbai, Bangalore, Kochi, and Hyderabad. The training pipeline is anchored by AIIMS, PGIMER Chandigarh, CMC Vellore, and a clutch of corporate flagships (Medanta, Apollo, Fortis, Max, Manipal, Narayana) where lead surgeons routinely log 5,000+ procedures across a 25-30 year career. For transarterial chemoembolisation (tace) specifically, India draws patients who want hospital tier-1 outcomes at 60-80% below US/UK list pricing — without compromising on implant brands, robotic platforms (da Vinci Xi is now in 80+ centres), or ICU staffing ratios.

Top medical hubs Delhi-NCR Mumbai Chennai Bangalore Hyderabad Kochi
  • 01

    Surgeon volume is the headline advantage — Indian cardiac and oncology centres run procedure volumes Western centres rarely see, which compresses learning curves and improves outcomes for complex cases.

  • 02

    English-language medical communication is the default; consent forms, imaging reports, and discharge summaries are issued in English by trained physicians, removing the translator step common in non-English destinations.

  • 03

    Visa-on-arrival or e-medical visa is available for citizens of ~165 countries, with same-week processing and double-entry options that make follow-up trips painless.

  • 04

    Direct flight connectivity from the GCC, East Africa, Bangladesh, Nepal, Sri Lanka, the UK, Singapore, Bangkok, and most major US gateways means under-12-hour transit for the majority of medical travellers.

Cost note. Indian pricing is driven by lower clinician salaries, real-estate cost-per-bed, and rupee parity — not by skipping protocols or using grey-market implants.

How to use this list

What to look for

  • Multidisciplinary tumor board meeting weekly; recommendations in writing.
  • Pathology lab capable of full molecular profiling (HER2, EGFR, BRAF, BRCA, MSI, PD-L1, comprehensive genomic profiling).
  • Treatment regimens benchmarked against published guidelines for your specific cancer.
  • Annual case volume on your specific cancer (not just 'cancer treatment').
  • Clinical trial access for relevant indications.
  • Supportive care infrastructure (antiemetic protocols, neutropenic support, transfusion access).
  • Communication infrastructure for shared care with home oncologist.

Volume benchmarks

Surgeon volume benchmarks

150+ cases/year on specific cancer Top-tier; outcomes typically reach published gold-standard ranges
75–150/year Strong; near-top-tier outcomes
30–75/year Moderate; outcomes acceptable for routine cases
Under 30/year on specific cancer Lower volume; consider higher-volume program for complex cases

Travel timing

When to travel to India

Peak window: October, November, December, January, February, March

Avoid: June, July, August, September

Cool, dry season runs October–March, particularly comfortable for recovery in Delhi, Mumbai, and Bangalore. Avoid June–September monsoon — flooding, humidity, and increased respiratory infections complicate recovery. Delhi winter (December–January) has serious air pollution; consider Bangalore or Chennai during this window if pollution-sensitive.

Questions

What to ask each program on this list

  1. 01

    Has my case been to tumor board, and can I see the recommendation in writing?

  2. 02

    What molecular markers have been tested on my tissue, and which determined the treatment plan?

  3. 03

    What's the goal of this treatment — curative, prolonging, or palliative — and how is success measured?

  4. 04

    What's your annual volume on my specific cancer?

  5. 05

    What's the side-effect profile of this regimen, and what's the supportive-care plan?

  6. 06

    How will my home oncologist receive treatment summary and continue care?